Lung Cancer study: NodeAI vs Surgeon
Official title The Development, Safety, and Feasibility of an Artificial Intelligence-Powered Platform (NodeAI) for Real-Time Prediction of Mediastinal Lymph Node Malignancy During Endobronchial Ultrasound Staging for Lung Cancer
ClinicalTrials.gov ID: NCT06540196
What this study is testing
- What it's testing
- The study will see if the AI device can give accurate, real‑time predictions of whether lymph nodes are cancerous, which could help doctors decide on treatment plans.
- Who it's for
- Adults with non‑small cell lung cancer who are scheduled for an endobronchial ultrasound staging procedure.
- What's involved
- Participants will undergo the standard ultrasound procedure while the AI device analyzes the images and provides a prediction. The device is used at the bedside and does not replace the doctor’s work.
- Time commitment
- The trial lasts only the duration of the ultrasound visit, typically a few hours, with no additional follow‑up visits required.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients ≥ 18 years of age diagnosed with suspected or confirmed NSCLC based on CT and PET scans that are referred for chest staging by EBUS-TBNA
- CT and PET scans completed
You likely can't join if
- Patients with cN0 disease AND peripheral tumors AND tumors \< 2 cm in diameter (those do not require chest staging)
The study team makes the final eligibility decision.
Where it is enrolling
- Hamilton, Ontario, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Hamilton, Ontario, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.